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Introduction as the predominant feature of the syndrome. In most
current diagnostic systems, mood is viewed as carrying
In this issue of the Journal, Sherman et al. (1997) de-
greater heuristic and practical value than other signs and
scribe the promise of genetic approaches for understand-
symptoms that might also be present, such as anxiety,
ing human behavior and point out a number of obstacles
cognitive impairment, or alteration in vegetative func-
to realization of this promise; these include the method-
tions (American Psychiatric Association 1994). Epidemi-
ological challenge of identifying genes for complex traits
ological studies have provided strong support for a ge-
and the societal challenge of appropriately using the
netic component in the etiology of these disorders
information that will be gained if such genetic-mapping
(Tsuang and Faraone 1990), particularly in comparison
efforts are successful. Genetic-mapping studies in hu-
with other classes of mental illness. However, as noted
mans rest on the premise that traits of interest can be
above, our current categorical classiﬁcation of psychiat-
reduced to one or more discrete phenotypes and that
ric disorders, although reliable, lacks demonstrated etio-
these phenotypes result, at least in part, from particular
logic validity. It is thus by no means certain that distur-
alleles at susceptibility loci of reasonably large effect. As
bance of mood represents the best indicator of common
discussed in this review, abundant evidence suggests that
genetic etiology for this class of conditions. For example,
severe bipolar mood disorder (BP) fulﬁlls this premise
major depressive disorder (MDD), the most common
better than other human behavioral traits (Tsuang and
mood disorder, is conceptualized as distinct from panic
Faraone 1990; Escamilla et al. 1997). The diagnosis of
disorder (PD), a common anxiety syndrome, although
BP is highly reliable, and its delineation as a distinct
two-thirds of patients with PD also will have a lifetime
syndrome has proved to be clinically useful in predicting
diagnosis of MDD (Breier et al. 1984), and comorbidity
course and response to treatment (Goodwin and Jami-
between the two syndromes is common (Kendler et al.
son 1990). However, one must keep in mind that this
1987; Coryell et al. 1988). Psychiatric disorders are,
diagnostic category, like all psychiatric classiﬁcations, is
of course, not unique in this regard, and similar issues
based on operational criteria (derived from a combina-
regarding the etiologic validity of diagnostic constructs
tion of epidemiological and clinical observations), rather
also complicate genetic mapping of many medical disor-
than on any anatomical or physiological evidence. This
ders.
fact differentiates psychiatric disorders from other etio-
The list of mood disorders most commonly includes
logically complex categories of disease, such as hyper-
MDD, dysthymic disorder (a more chronic but generally
tension or diabetes mellitus. In this review we discuss
less severe depressive disorder), BP (in which episodes
our current understanding of the genetic basis of BP and
of major depression alternate with mania), cyclothymic
other mood disorders and indicate how our body of
disorder (characterized by many episodes of brief and/
knowledge has been inﬂuenced by different approaches
or less severe depressions alternating with symptoms of
to the deﬁnition of disease phenotypes.
mild mania (hypomania)), and mood disorders due to a
The term ‘‘mood disorders’’ encompasses a group of
general medical condition or induced by substance
conditions in which a disturbance of mood is recognized
abuse. BP is divided further into BP-I (MDD and severe
mania) and BP-II (MDD and hypomania), and both of
these categories also often are referred to as ‘‘manic-
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(notably schizophrenia) as independent entities, a sub- were conducted §2 decades ago, using (a) phenotype-
assignment methods that currently would not be widelystantial number of individuals are afﬂicted with schizo-
affective disorder, in which disturbances in thought pro- accepted and (b) diagnostic categorizations that differ
from those employed in almost all recent genetic-map-cesses are as prominent as the mood alteration
(Escamilla et al. 1997). ping studies. An example is the study by Bertelsen et al.
(1977), discussed above, which has had a substantial
inﬂuence on current views regarding the genetic basis ofGenetic Epidemiology of Mood Disorders
mood disorders. The determination of phenotype in that
investigation derived from an unstructured psychiatricUncertainty regarding the etiologic relationship be-
tween BP and other psychiatric disorders has not been interview conducted by a single individual; in contrast,
most current investigators would accept diagnostic-in-resolved by a large number of family, twin, and adoption
studies aimed at evaluating the degree of familial aggre- terview data only if these were collected by standardized
interviews. Additionally, the ﬁndings of Bertelsen et al.gation and heritability of various mood disorders. Nev-
ertheless, although family studies of BP, conducted over (1977) were based on diagnostic criteria different than
those currently in use—for example, combining individ-a period of several decades, have utilized several differ-
ent designs, including varying deﬁnitions of what consti- uals with hypomania and individuals with mania into
the same category. Reexamination of epidemiologicaltutes BP, they consistently have demonstrated familial
aggregation of both severe and mild mood disorders. studies such as that by Bertelsen et al. (1977) further
emphasizes the special difﬁculty of psychiatric genetics;One of the most striking ﬁndings of these studies has
been that BP shows far greater familial aggregation than there is inherent subjectivity in recording even individual
behavioral features, let alone in determining categoricalother mood disorders. For example, Weissman et al.
(1984) observed a relative risk for BP of almost 25, diagnoses that change over time. This fact makes the
delineation of affected status in current studies as prob-compared with a relative risk of Ç3.0 for MDD. Simi-
larly, twin studies have indicated a higher heritability lematic as the proper interpretation of past data.
It is not likely that we will attain a more reﬁned ap-for BP, compared with that for other forms of mood
disorder. For example, the classic twin study by Bertel- proach for diagnostic classiﬁcation of mood disorders
until we begin to identify the genes that underlie riskson et al. (1977), utilizing the Danish Twin Registry,
indicated a concordance rate, for narrowly deﬁned BP, for these disorders. From that point we may learn to
make distinctions ﬁner than are now possible betweenof .79 for MZ twins, versus .19 for DZ twins (as op-
posed to .54 and .24, respectively, for major depression). different classes of mood disorders and also may dis-
cover that particular (and currently unexpected) pheno-Although most epidemiological studies suggest that
some cases of MDD probably are genetically related to typic features are etiologically related to one another.
Such use of genetics to redeﬁne phenotypic categoriesBP, only inconclusive results have been obtained from
efforts to identify particular MDD subtypes that are has, of course, been one of the most tangible results
of positional cloning of genes responsible for relativelymost likely to reﬂect a shared genetic etiology with BP
(Goodwin and Jamison 1990). simple disorders. Such diagnostic reﬁnement, however,
will not be possible for mood disorders unless the cur-It is instructive to compare the evidence showing the
high degree of heritability of narrowly deﬁned BP to rently available classiﬁcation schemes will permit us to
ﬁrst map the responsible genes. Genes for several pheno-that for either of the traits used for illustrative purposes
by Sherman et al. in this issue of the Journal—namely, typically complex (nonpsychiatric) disorders have now
been mapped. Success in mapping such traits usuallyschizophrenia and emotional stability; for example, the
MZ concordance rate of .79 for BP (Bertelsen et al. has depended on the delineation of narrowly deﬁned
phenotypes that are most likely to share common genetic1977) compares with an MZ concordance rate of .46
for schizophrenia (results from several studies, pooled causation, as determined by examination of the ﬁndings
of genetic-epidemiological studies (McInnes and Freimerby Sherman et al.). The calculated heritability of BP
has been estimated at .59 (Tsuang and Faraone 1990), 1995; Escamilla et al. 1997). These examples could be
used to guide our approach to genetic-mapping investi-compared with .27–.61 for emotional stability (as com-
piled by Sherman et al.). gations of mood disorders; although the epidemiological
studies of these syndromes are imperfect, they clearlySherman et al. point out that twin studies have a num-
ber of inherent limitations and that their results there- suggest that severe BP (i.e., BP-I) should be considered
such a narrowly deﬁned phenotype.fore should be interpreted cautiously. Such caution is
particularly warranted for psychiatric disorders, because
Genetic Mapping Studies of Mood Disorderof the special complexities that we already have noted.
Relatively little attention has been paid to the fact that The effort to map genes for BP may have attracted
more scrutiny from the scientiﬁc and general media thanthe majority of twin studies of psychiatric syndromes
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has the search for genes responsible for any other human Order Amish community suggest possible SML inheri-
tance only for BP-I, not for other mood disorders (Paulstrait. Remarkably, several cycles of misplaced excite-
ment and exaggeration of failure were widely reported et al. 1995). These studies should not be interpreted as
supporting SML inheritance of BP (Craddock et al.before a single study had even attempted to screen the
entire genome for linkage to BP. In fact, the initial series 1997; Spence et al. 1997), but they clearly indicate that
such a model is unlikely for broadly deﬁned mood disor-of studies suggesting localization of BP genes on chro-
mosomes 11 (among the Old Order Amish) and X ders. Despite these observations, many (but not all) sub-
sequent linkage studies have continued to focus on data(among non-Ashkenazi Israeli Jews) were reported at
a time when the available genetic markers permitted sets in which a high proportion of the genetic informa-
tion derives from individuals with diagnoses other thanevaluation of linkage across only a tiny fraction of the
entire genome (Baron et al. 1987; Egeland et al. 1987) BPI. Efforts continue to attempt to identify forms of
mood disorder that reﬂect a common genetic etiologyand when linkage had only been demonstrated for a
handful of diseases, all with clear-cut Mendelian trans- with BP; these remain unsuccessful (Blacker et al. 1996).
Beginning in the early 1990s, the availability of highlymission. These initial linkage studies were predicated
on two broad assumptions: ﬁrst, that relatively simple polymorphic microsatellite markers had a major impact
on genetic-linkage studies for BP. Several groups re-Mendelian models could account for the transmission of
an enormous range of mood-disorder phenotypes and, ported single suggestive localizations for BP genes, loci
based on testing multiple markers in several locationssecond, that the power of linkage approaches was sufﬁ-
ciently great that BP genes could be identiﬁed even if but not, however, on complete screening of the genome.
These studies utilized mainly cosmopolitan collectionsthe ﬁrst assumption was incorrect. With the beneﬁt of
hindsight it is obvious that such preconceptions were of pedigrees fromNorth America and Europe. Examples
of these results include possible BP localizations on chro-naive, although it should be noted that the results of the
studies, particularly that of the Amish study, were mosomes 21q (Straub et al. 1994), in the pericentro-
meric region of 18 (Berrettini et al. 1994), on 16pwidely accepted until follow-up examination of the same
pedigrees failed to support the original ﬁndings (McIn- (Ewald et al. 1995), and on 5p (Kelsoe et al. 1996). The
results of Berrettini et al. (1994) have attracted particu-nes and Freimer 1995). It became clear that investigators
had failed to account for uncertainty in the assignment lar attention, because they have been supported by an
independent investigation using a different set of Northof phenotypes; for example, the fall in the evidence for
linkage on chromosome 11 in the Amish was due largely American pedigrees (Stine et al. 1995). The results sup-
porting BP linkage in the pericentromeric region of chro-to the development of mood disorder in two previously
unaffected individuals whose marker genotypes in this mosome 18 are conﬁned largely to families in which BP
appears to be inherited through the paternal lineage.chromosome region differed from those of the originally
affected family members (Kelsoe et al. 1989). Addition- This intriguing observation has suggested the possibility
of a parent-of-origin effect. It is unclear what mechanismally, the majority of the linkage information in both the
Amish and Israeli studies derived from individuals with would account for such a ﬁnding; however, it may be
noteworthy that this region contains one of the mostdiagnoses other than classic BP—for example, unipolar
MDD (Baron et al. 1987, 1993; Egeland et al. 1987; dramatic instances, in the genome, of suppression of
male recombination relative to female recombinationKelsoe et al. 1989). As indicated above, it already had
been known, from family studies, that the relative risk (Silverman et al. 1996).
Several recently reported linkage studies of BP differfor BP was substantially greater than that for MDD
(Weissman et al. 1984) and, from twin studies, that the from previous ones in three important respects: (1) Link-
age analysis is focused primarily on individuals withheritability of BP was substantially greater than that for
MDD (Bertelsen et al. 1977). severe mood disorder (BP-I only in Ginns et al. 1996;
McInnes et al. 1996; and BP-I and BP-II in BlackwoodSubsequent to these initial ‘‘follow-up’’ linkage stud-
ies, additional efforts have been made to evaluate the et al. 1996) (2) The bulk of information for linkage
is derived from affected, rather than from apparentlydegree to which the inheritance patterns of various
forms of mood disorder are consistent with the models unaffected, individuals (Blackwood et al. 1996; Ginns
et al. 1996; McInnes et al. 1996). (3) Results can beused in most linkage studies—that is, the assumption
that the action of a single major locus (SML) is involved. interpreted in the light of complete screening of the ge-
nome in the relevant study populations (Blackwood etSpence et al. (1995), in the largest such study, have
shown in a British Columbian sample that, although al. 1996; Ginns et al. 1996; McInnes et al. 1996).
What do these studies tell us? In the study by Black-there is good evidence for SML inheritance of BP (in
particular, of BP-I), the evidence argues against SML wood et al. (1996), an argument could be advanced for
statistically signiﬁcant linkage to chromosome 4p. Thisinheritance for MDD and other psychiatric disorders.
Even more strikingly, segregation analyses of the Old result was limited to a single extended Scottish pedigree
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and was not found in other pedigrees from the same prove spurious. In this respect the results of genome-
screening studies of BP are roughly comparable to thosepopulation. Additionally, the evidence for linkage de-
pended on the inclusion of BP-II individuals. Ginns et recently observed for other complex traits, such as insu-
lin-dependent diabetes mellitus and multiple sclerosisal. (1996), in a new analysis of the Old Order Amish,
identiﬁed regions on chromosomes 6, 13, and 15 in (Davies et al. 1994; Hashimoto et al. 1994; Ebers et al.
1996; Haines et al. 1996; Kuokkanen et al. 1996;which excessive allele sharing among affected individu-
als suggest the possible location of loci for BP-I suscepti- Sawcer et al. 1996). Some commentators have suggested
that the difﬁculties and uneven rate of progress inherentbility. None of these possible localizations, however,
attain statistical signiﬁcance. McInnes et al. (1996), in in mapping genes for complex traits are somehow partic-
ular to BP, perhaps because of the glib references thata study of two extended pedigrees from the genetically
homogenous population of Costa Rica, identiﬁed possi- can be made to the euphoria of apparent success and
the dysphoria of apparent failure (Morell 1996; Rischble localizations for BP-I in several chromosomal re-
gions, notably 11p, 18p, and 18q. The 18q localization and Botstein 1996). Such publicity may have the unfor-
tunate result of generating undue pessimism, among thewas supported by identiﬁcation of extremely long haplo-
types shared by most of the affected individuals in both scientiﬁc community and the general public, regarding
the possibility of ultimately elucidating the genetic basisfamilies, including several alleles that are very rare in the
general Costa Rican population (Freimer et al. 1996). In of BP and other mood disorders.
the Costa Rican study the linkage evidence also did not
attain statistical signiﬁcance. Each of these reports, how- Societal Implications
ever, identiﬁes regions of the genome that require more
intensive study. In two cases (Blackwood et al. 1996; Even if, in the near future, one or more susceptibility
genes for bipolar disorder are identiﬁed, it will be difﬁ-Freimer et al. 1996), the suggested linkage ﬁndings are
accompanied by extended marker haplotypes in the ma- cult, as Sherman et al. point out, to know how to utilize
such information clinically. The societal stigma of bipo-jority of affected individuals within the relevant pedi-
grees. These haplotypes indicate that the designated re- lar disorder and other psychiatric conditions, as well as
their variable course, make it likely that the problemsgions are identical by descent (IBD) among affected
individuals; since each of these studies draws on subjects already identiﬁed in the genetic testing of other common
complex diseases, such as breast cancer and colon can-from genetically homogeneous populations, there is the
possibility of testing whether these regions are shared cer, will be multiplied when genetic testing in psychiatric
disorders becomes feasible. The opportunity exists,IBD by other (apparently unrelated) patients from the
same populations. This opportunity also offers the hope however, to identify the salient issues and to plan for
the day when genetic risk of psychiatric illness can bethat the region of IBD sharing can be narrowly deline-
ated on the basis of the expectation that more distantly assessed reliably. For example, our group has surveyed
individuals with mood disorder, their friends and rela-related affected individuals will share small regions IBD,
as a result of recombination over several generations tives, and health-care providers, to explore the implica-
tions of genetic testing in bipolar disorder (Smith et al.that separate them from their common ancestor(s). Ulti-
mately it may be possible, by use of such isolated popu- 1996). We have observed that reproductive decisions
and attitudes toward presymptomatic testing in childrenlations, to deﬁne, for BP loci, candidate regions sufﬁ-
ciently narrow to permit positional cloning of causative differ markedly between consumer groups and health-
care providers and that they depend greatly on presumedgenes.
It is unlikely that a single major susceptibility gene severity of illness and the availability of as yet undeter-
mined preventive strategies that might ameliorate theexists that is responsible for a high proportion of BP
cases in all populations. How, then, should we interpret severity or course of illness. Individuals who are likely
to pursue genetic testing may ﬁnd it difﬁcult to acceptthe fact that several genome-screening studies have high-
lighted multiple possible chromosomal regions that the inherent uncertainty in the prediction of genetic risk
and may misinterpret the information in such a way ascould contain BP-susceptibility genes? Genetic-mapping
studies of complex traits may be viewed as a highly to adversely affect their own and/or other family mem-
ber’s life experiences. In our study, psychiatric physi-iterative process, in which initial genome-screening stud-
ies serve to propose hypotheses to be tested through cians were much more likely to endorse termination of a
pregnancy than were either patients and support-groupadditional investigation (McInnes et al. 1996). Ac-
cording to this view, one does not expect the explosive members or medical students, if informed of a probable
fetal inheritance of bipolar disorder. This difference inprogress toward gene identiﬁcation that has character-
ized the study of simple Mendelian traits (Jamison and interpretation of data was particularly evident in scenar-
ios in which the likelihood of developing BP disorderMcInnis 1996), and we can anticipate that many (if not
most) of the currently suggested BP localizations will was high and in which the course of illness was severe.
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